The Amsterdam-headquartered non-governmental organisation (NGO) seeks to impact a wide range of pharmaceutical policy issues, everything from international trade agreements and EMA rules to oversight of drug safety by the European Commission.
These efforts will be further facilitiated by a new operation in Europea's political capital according to HAI policy advisor Aliénor Devalière who said: “Our new location will put us in the thick of policy developments as they happen and allow us to work more closely with partners and policy-makers.”
This was echoed by Tim Reed, the NGO’s executive director, who said: “This expansion is an important step in truly bringing our message of equitable medicines access to the heart of the European Union.”